QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PRGO

QT68Perrigo Company plc
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic·USA
Latest market price
10.25
+0.09+0.89%
OverviewShort InterestFilings
PRGOQT68Perrigo Company plc·NYSE
OverviewShort InterestFilings
10.25+0.89%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01LNTH+0.65%$103.86
Snapshot
Index-P/E-EPS (ttm)-13.11
Insider Own0.96%
Shs Outstand138.37M
Perf Week-5.96%
Market Cap1.41BForward P/E4.33EPS next Y2.37Insider Trans0.28%Shs Float-Perf Month-3.39%
Enterprise Value4.85BPEG0.00EPS next Q0.39Inst Own-Short Float-Perf Quarter6.22%
Income-1813222177.00P/S0.34EPS this Y116.15%Inst Trans-Short Ratio-Perf Half Y-21.27%
Sales4.18BP/B0.56EPS next Y11.77%ROA-22.77%Short Interest-Perf YTD-26.36%
Book/sh18.06P/C7.44EPS next 5Y8.18%ROE-50.65%52W High28.44 -63.96%Perf Year-60.98%
Cash/sh2.58P/FCF13.05EPS past 3/5Y-ROIC3.37%52W Low9.23 11.05%Perf 3Y-
Dividend Est.1.16 (11.32%)EV/EBITDA-3.92Sales past 3/5Y-1.51% 0.79%Gross Margin34.17%Volatility3.54% 3.74%Perf 5Y-
Dividend TTM1.16 (11.32%)EV/Sales1.16EPS Y/Y TTM305.60%Oper. Margin5.67%ATR (14)0.55Perf 10Y-
Dividend Ex-DateMay 29, 2026Quick Ratio1.59Sales Y/Y TTM-4.46%Profit Margin-43.50%RSI (14)40.16Recom2.67
Dividend Gr. 3/5Y3.71% 5.21%Current Ratio2.72EPS Q/Q-28.33%SMA20-5.89%Beta1.12Target Price36.20
Payout-8.73%Debt/Eq1.52Sales Q/Q-7.18%SMA50-8.41%Rel Volume1.90Prev Close10.16
Employees8,379LT Debt/Eq1.33EarningsAug 05SMA200-29.49%Avg Volume2.71MPrice10.25
IPO DateDec 17, 1991Option/ShortYes / YesEPS/Sales Surpr.10.26% -6.38%Net Debt/EBITDA-2.78Volume5,131,254Change0.89%
Analyst Ratings
DateActionAnalystRatingTarget
Nov-06-25ReiteratedCanaccord GenuityBuy$40 → $20
Nov-06-25DowngradeJP MorganOverweight → Neutral
Oct-27-25ReiteratedJefferiesHold$30 → $23
Aug-07-25ReiteratedCanaccord GenuityBuy$40
Jan-06-25DowngradePiper SandlerOverweight → Neutral
Sep-23-24DowngradeJefferiesBuy → Hold$30
Jun-13-24ReiteratedPiper SandlerOverweight$39 → $36
Apr-08-24ReiteratedPiper SandlerOverweight$37 → $39
Nov-17-23InitiatedPiper Sandler$37
Sep-14-22UpgradeArgus ResearchHold → Buy
Latest News
Jun-15-26
Jun-15-2608:05AM
Cramer Says Credo Technology Is 'Just So Good' — But Warns This Healthcare Name Is A 'Value Trap'Benzinga
Jun-12-26
Jun-12-2606:45PM
Dividend Champion, Contender, And Challenger Highlights: Week Of June 14SeekingAlpha
10:33AM
Perrigo Company: Expected Improvement In Latter Part Of FY26 Doing Little For Investor SentimentSeekingAlpha
Jun-10-26
Jun-10-2601:12AM
Tech Buckles Again, An Apache Goes Down Over Hormuz, And Oracle Takes The StandChartMill
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue4,1784,2534,373
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A2,7502,7592,831
Gross Profit1,4281,4951,543
Selling, General and Administrative Excl. Other3765271,113
Research and Development9495112
Other Operating Expense723529205
Operating Income237343113
Interest Expense165163188
Unusual Expense
———
Non-Operating Income (Expense)1,7881,4796
Net Income Before Taxes-1,715-1,298-81
Income Taxes7810480
Consolidated Net Income-1,817-1,425-172
Net Income From Continuing Operations-1,791-1,402-161
Net Income-1,817-1,425-172
EPS (Recurring)-13.11-10.29-1.25
EPS (Basic, Before Extraordinaries)-13.11-10.29-1.25
EPS (Diluted)-13.11-10.29-1.25
EBITDA-1,239-798433
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio0.340.45—
Gross Margin34.1835.1535.28
Operating Margin5.678.062.58
Net Margin-43.49-33.51-3.93
Shares Outstanding139139137
Market Capitalization1,4251,935—
Operating Lease Expense
———
Insider Trading Volume
$10.88$9.84$8.81$7.78$6.74● Close Price0.00K101.21K202.41K303.62K404.82KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Alford Bradley ADirectorJun 12 '26Option Exercise5.501,95210,72645,934Jun 16 12:00 AM
Parker Geoffrey M.DirectorJun 12 '26Option Exercise5.501,95210,72633,686Jun 16 12:00 AM
Lockwood-Taylor Patrickother: Former CEO and directorJun 05 '26Option Exercise5.4250,460273,241136,076Jun 09 12:00 AM
Willis RobertEVP & CHROJun 05 '26Option Exercise5.426,88237,26652,365Jun 08 12:00 AM
Lennox AbigailEVP and CSOJun 05 '26Option Exercise5.427,64641,4037,645Jun 08 12:00 AM
Bezerra Eduardo GuaritaEVP & Chief Financial OfficerJun 05 '26Option Exercise5.4218,35099,36586,935Jun 08 12:00 AM
Ball DavidEVP & CBDOJun 05 '26Option Exercise5.425,73431,0507,784Jun 08 12:00 AM
Atkinson CharlesEVP, General Counsel & Sec.Jun 05 '26Option Exercise5.4213,38072,45313,379Jun 08 12:00 AM
Khoury RobertoEVP and President of CSCIJun 05 '26Option Exercise5.4235,804193,87817,433Jun 08 12:00 AM
Samuelson JonasDirectorMay 14 '26Option Exercise5.4214,61079,1868,899May 15 12:00 AM
Parker Geoffrey M.DirectorMay 14 '26Option Exercise5.4214,61079,18636,217May 15 12:00 AM
Brown Julia MDirectorMay 14 '26Option Exercise5.4214,61079,18615,339May 15 12:00 AM
Manzone AlbertDirectorMay 14 '26Option Exercise5.4214,61079,18619,860May 15 12:00 AM
Alford Bradley ADirectorMay 14 '26Option Exercise5.4214,61079,18648,465May 15 12:00 AM
O'Connor DonalDirectorMay 14 '26Option Exercise5.4214,61079,18637,942May 15 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR